The Economic Times daily newspaper is available online now.

    Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status

    Synopsis

    Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status

    IPOET Spotlight
    After a healthy response to the IPO, Nephro Care is likely to finalize the share allotment process later today. Investors can check the status of Nephro Care by logging in to the official website of the registrar, which is Bigshare Services in this case.

    Follow the step by step process mentioned below to check the status of allotment.

    Step 1: Visit the IPO Allotment Status page on Bigshare Services website (https://ipo.bigshareonline.com/IPO_Status.html)

    Step 2: Select IPO from the dropdown

    Step 3: Put Application number and enter captcha and 'Submit'.

    Nephro Care GMP

    In the unlisted market, the company's shares are trading with a premium of Rs 180. If the trends sustain, the company's shares are expected to list with gains of 300% on July 5. The company has priced the IPO at Rs 90 at the upper end.

    The SME IPO of Nephro Care was subscribed just over 700 times at close. The IPO was entirely a fresh equity issue of 45.84 lakh shares.

    The net proceeds from the public offer will be used for setting up a multi-speciality hospital in the name of vivacity multi specialty hospital (unit of Nephro Care) in Kolkata and other general corporate purposes.

    Deepak Parekh-backed multi-speciality healthcare provider Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

    CKD is a severe public health issue in India. As per government estimates, nearly 2,20,000 patients develop end-stage renal disease (ESRD) annually in India, leading to an additional annual dialysis demand of 34 million treatment sessions. Unfortunately, in India, renal insufficiency treatment focuses more on curative nephrology rather than preventive and holistic solutions.

    For the period ended December 2023, the company clocked total revenues of Rs 19.75 crore and net profit of Rs 3.4 crore.

    Corporate Capital Ventures is acting as the lead manager to the issue and Bigshare Services is the registrar.

    (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)


    (You can now subscribe to our ETMarkets WhatsApp channel)

    (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more

    (You can now subscribe to our ETMarkets WhatsApp channel)

    (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more
    The Economic Times

    Stories you might be interested in